Endometriosis affects millions of women worldwide, yet diagnosis has traditionally taken an average of more than nine years in the UK. Excitingly, that is set to change.
Following the latest draft guidance from NICE, EndoSure has been recommended for early NHS use as a non-invasive diagnostic technology that could significantly reduce the time taken to diagnose endometriosis. The announcement has been widely covered by leading UK media, highlighting the growing recognition of innovative diagnostic solutions in women’s healthcare.
As the exclusive UK partner for EndoSure, Lawmed is proud to support the introduction of this groundbreaking technology, helping healthcare providers deliver faster, more accessible diagnosis for patients experiencing symptoms of endometriosis.
Read the latest announcements and coverage:
- NICE – https://www.nice.org.uk/news/articles/new-technologies-for-endometriosis-diagnosis-in-primary-care
- Sky News – https://news.sky.com/story/new-endometriosis-tests-set-to-dramatically-speed-up-diagnosis-13561013
- ITV News – https://www.itv.com/news/2026-07-06/new-game-changer-tests-for-endometriosis-given-green-light-on-nhs
- BBC News – https://www.bbc.co.uk/news/articles/c4gyy8jdn3eo
- The Guardian – https://www.theguardian.com/society/2026/jul/07/rapid-endometriosis-tests-to-be-made-available-on-nhs-in-england-and-wales
At Lawmed, we remain committed to bringing innovative medical technologies to the UK and improving patient outcomes through earlier diagnosis and better access to care.
Learn more about It’s About Time and our women’s health solutions
